MARKETS

BSE Prices delayed by 5 minutes... Prices as on Jun 18, 2019   ABB India 1540.6 [ 0.57% ]ACC 1526.45 [ 1.09% ]Ambuja Cements Ltd. 210.15 [ 2.16% ]Asian Paints Ltd. 1380.4 [ -1.53% ]Axis Bank Ltd. 776.25 [ -0.06% ]Bajaj Auto Ltd. 2856.8 [ 0.64% ]Bank of Baroda 116.6 [ -0.04% ]Bharti Airtel 345.65 [ 0.63% ]Bharat Heavy Ele 68.55 [ 1.93% ]Bharat Petroleum 385.7 [ 2.20% ]Britannia Ind. 2868.1 [ -1.06% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 547.4 [ 0.48% ]Coal India 260.35 [ 2.02% ]Colgate Palm. 1142.2 [ -1.17% ]Dabur India 387.85 [ -3.23% ]DLF Ltd. 173.25 [ 0.20% ]Dr. Reddy's Labs 2590 [ 1.54% ]GAIL (India) Ltd. 308.05 [ 0.70% ]Grasim Inds. 880.45 [ 0.19% ]HCL Technologies 1087.7 [ 1.28% ]HDFC 2154.3 [ -0.79% ]HDFC Bank 2416.8 [ -0.21% ]Hero MotoCorp 2667.55 [ 0.75% ]Hindustan Unilever L 1807.45 [ -0.49% ]Hindalco Indus. 190.05 [ -1.96% ]ICICI Bank 422.2 [ 1.88% ]IDFC L 34.85 [ 0.29% ]Indian Hotels Co 148.8 [ 1.88% ]IndusInd Bank 1408.55 [ 0.66% ]Infosys 750.65 [ 1.38% ]ITC Ltd. 275.6 [ 0.11% ]Jindal St & Pwr 151.5 [ -2.07% ]Kotak Mahindra Bank 1462.65 [ 0.23% ]L&T 1504.95 [ 0.40% ]Lupin Ltd. 708.75 [ 0.28% ]Mahi. & Mahi 625.95 [ 0.28% ]Maruti Suzuki India 6437.05 [ -2.20% ]MTNL 7.83 [ -5.89% ]Nestle India 11454.95 [ -0.15% ]NIIT Ltd. 104.55 [ -0.33% ]NMDC Ltd. 105.2 [ -0.66% ]NTPC 132.5 [ 0.23% ]ONGC 166.1 [ 0.88% ]Punj. NationlBak 75.4 [ -0.66% ]Power Grid Corpo 197.7 [ 1.88% ]Reliance Inds. 1282.55 [ 0.08% ]SBI 340.25 [ 0.74% ]Vedanta 168 [ 2.47% ]Shipping Corpn. 29.05 [ 0.35% ]Sun Pharma. 378.4 [ -1.11% ]Tata Chemicals 621.55 [ 0.06% ]Tata Global Beverage 247.55 [ 0.84% ]Tata Motors Ltd. 158.3 [ -0.35% ]Tata Steel 472.75 [ -0.06% ]Tata Power Co. 64.35 [ -0.31% ]Tata Consultancy 2251.7 [ 0.27% ]Tech Mahindra Ltd. 741.1 [ 0.59% ]UltraTech Cement 4512.95 [ 1.30% ]United Spirits 535.3 [ -0.75% ]Wipro Ltd 297.8 [ -0.48% ]Zee Entertainment En 339.75 [ 0.50% ]

News Details

You can view in detail.
Cipla bags approval for Isoproterenol Hydrochloride Injection 14/06/2018 09:26

Cipla Limited (“Cipla”), has said that it has received final approval for its Abbreviated New Drug Application (ANDA) for Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, single - use sterile Ampoule from the United States Food and Drug Administration (US FDA ).

Cipla’s Isoproterenol Hydrochloride Injection USP, 0.2mg/mL, ampoule is AP - rated generic therapeutic equivalent version of Hospira Inc’s Isuprel ® Injection, 0.2mg/m.

According to IQVIA (IMS Health), Isuprel Injection and its generic equivalents had US sales of approximately USD 1 48 M for the 12-month period ending April 2018.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Meanwhile, shares of the company were trading at Rs 589.30 apiece up 1.36 per cent from the previous close at 09:28 hrs on BSE.

LOAD MORE